Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Clinical Chemistry, ABX Pentra Lipase CP, ABX Pentra 400/Pentrac400, REF: A11A01631, Model/Part # 1220001631, UDI # 03610230004944

FDA Recall Z-0119-2020 · Posted None

Recall StatusTerminated
Product CodeCHI
Date Initiated2018-10-30
Date Terminated2020-06-16
Product Quantity1539 Chemistry Analyzers

Reason for Recall

Potential for chemical analyzer to report abnormal results due to an interference with triglycerides CP and Cholesterol CP. An over estimation of the lipase concentration could be observed and a patient result could be declared abnormal by the instrument due to these interferences instead of normal result < 38 U/L (or < reference value used in your laboratory).

Firm Action

A "field Safety Notice" was mailed to all consignees on XX/XX/XXXX via XXXX. The field safety notice informed customer of the following: 1. If your lipase result is > 38 U/L (or the reference (normal) value of your laboratory) rerun lipase alone: - If result is still > 38 U/L(or the reference value of your laboratory), report the result as abnormal. - If result is < 38 U/L(or the reference value of your laboratory), report the result as a normal. 2. To avoid rerun, another option is to perform lipase test in batch mode (all lipase tests executed consecutively in a same run). 3. Those recommendations will be added on the reagent notice for lipase test. The last revisions of these documents are available on our Documentation web site. 4. Please share this information with your laboratory staff, and retain this notification as part of your Quality System documentation. 5. Please complete and return the enclosed response form within 10 days, in order for us to verify your understanding of this Field Information. 6. If you have any questions regarding this Product Corrective Action, please contact your local Horiba Medical representative or our Technical Service Department at 888-903-5001, option 3, option 2.

Root Cause

Device Design

Distribution Pattern

US: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑